Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab

Timothy J. Hahn, Daniel J. McKeone, James W. Beal, Jessica E. Ericson, E. Scott Halstead

Open source

DOI
10.3389/fped.2023.1340360
Published
2024-01-18
Container
Frontiers in Pediatrics
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fped.2023.1340360,
  title = {Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab},
  author = {Timothy J. Hahn and Daniel J. McKeone and James W. Beal and Jessica E. Ericson and E. Scott Halstead},
  year = {2024},
  journal = {Frontiers in Pediatrics},
  doi = {10.3389/fped.2023.1340360},
  url = {https://doi.org/10.3389/fped.2023.1340360}
}

RIS

TY  - JOUR
TI  - Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab
AU  - Timothy J. Hahn
AU  - Daniel J. McKeone
AU  - James W. Beal
AU  - Jessica E. Ericson
AU  - E. Scott Halstead
PY  - 2024
JO  - Frontiers in Pediatrics
DO  - 10.3389/fped.2023.1340360
UR  - https://doi.org/10.3389/fped.2023.1340360
ER  - 

APA

Hahn, T. J., McKeone, D. J., Beal, J. W., Ericson, J. E., & Halstead, E. S. (2024). Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2023.1340360

Source records